The major findings of this study are related to the application of UHF MRI technology to study the early development of β1aabs-driven autoimmune cardiac dysfunction and to the identification of β3-AR as key actor of a counterbalancing pathway preventing the occurrence of DCM in this model. This evidence concerns the gene ADRB3 and familial dilated cardiomyopathy.